Fantasy Baseball Injury Updates: Bobby Miller, Nick Lodolo, Joe Musgrove

During football season, people complain about how many injuries there are, but those people don’t follow fantasy baseball. Tracking fantasy baseball injuries is a full-time task because we have players going on and off the injured list (IL) all season. It’s a frustrating aspect of fantasy baseball, but it does allow you to feast on the waiver wire and trade market to capitalize on some of these moves.

With that in mind, let’s dive into the fantasy baseball injury updates for this week.

2024 Fantasy Baseball Injury Stashes (Week 8)

Here are fantasy baseball injury updates for ailing pitchers.

Pitchers to Stash Right Now

Bobby Miller (SP – LAD)

This IL stint has been a little longer than fantasy managers were hoping, with Bobby Miller out since April 10 with a shoulder issue. The good news is that he threw two simulated innings on Wednesday in Arizona. That means another sim game or a rehab assignment could be up this weekend. We’d expect him to need one or two rehab starts before returning to the Dodgers in the next two weeks.

Nick Lodolo (SP – CIN)

Nick Lodolo was the most recent addition to the IL, suffering a groin strain in his most recent start. This guy started the season on the IL and only made seven starts in an injury-riddled 2023 campaign. That’s a scary trend for such a young pitcher, especially since he has a 3.34 ERA, 0.94 WHIP, and 11.1 K.9 rate in a breakout season. There is some optimism that this will be a minimum stint on the IL. That’s all fantasy managers could hope for.

Joe Musgrove (SP – SD)

Joe Musgrove is having the worst year of his career. San Diego was hopeful an IL stint would get him back on track. He’s steadily progressed in his rehabilitation, completing a bullpen session on Wednesday. There’s some thought he could be back with the Padres on Sunday, but that would be a matchup with Atlanta. We prefer a friendlier opposition, but getting him back is excellent, no matter who he faces. This is also a fantastic buy-low opportunity, with Musgrove maintaining a 3.05 ERA and 1.09 WHIP over the last three years.